Androgens 2010 » Programme

Thursday 25th November

9.00-9.45: Registration: Campus Gasthuisberg, in the foyer of the ON2 building
9.45-10.00: Welcome

10.00-10.30: Tapio Visakorpi: Functional significance of AR overexpression in prostate cancer
10.30-11.10: Karen Knudsen: Cell cycle regulation of AR accumulation and signaling: implications for prostate cancer
11.10-11.25: Greg Brooke: Fused in Ewing’s Sarcoma/Translocated in Liposarcoma is a novel modulator of androgen-dependent cell cycle progression and prostate cancer growth
11.25-11.55: Coffee break
11.55-12.10: Margaret Centenera: Targeting Androgen Signaling in Prostate Cancer using a Combinatorial Approach
12.10-12.25: Auriane Kroiss: miR-135a, an androgen regulated microRNA which targets the ANXA7 tumor suppressor gene
12.25-12.55: Jan Trapman: ETV1 and ETV1 fusion partners in prostate cancer
12.55-14.00: Lunch

14.00-14.40: Mike Stallcup: Differential mechanistic and physiological contributions of transcriptional coregulators in steroid hormone action
14.40-14.55: Päivi Pihlajamaa: Genome-wide analysis of androgen receptor binding sites in mouse prostate
14.55-15.10: Eva Estebanez-Perpina: Allosteric Effects in the Androgen Receptor Proved by Molecular Dynamics
15.10-15.40: Adriaan Houtsmuller: Molecular mechanisms of transcription regulation by androgen receptors in living cells
15.40-16.00: Coffee break
16.00-16.30: Jacques Young: Low AR expression and absence of Anti-Mullerian Hormone repression in Sertoli cells during early human testis development
16.30-16.45: Jinpei Kumagai: Changes in steroidogenic enzyme expression in castration-resistant prostate cancer clones of the LAPC4 cell line
16.45-17.15: Craig Robson: Ubiquitin mediated regulation of AR function
17.15-17.45: Bernard Haendler: Histon demethylation and steroid receptor function
17.45-18.00: Isabelle Geron: Homogeneous Proximity Assays To Study Histone H3 Epigenetic Modifications
18.00-19.00: poster session
19.00u Dinner

8.30-9.00: Natacha Prevarskaya: Ion channels in prostate cancer
9.00-9.30: Qianben Wang: Regulation of G2/M Phase Genes in Androgen Receptor Positive and Negative Castration-Resistant Prostate Cancer
9.30-10.10: Wayne Tilley: AR in breast cancer
10.10-10.25: Lien Spans: Exome sequencing of the LNCaP prostate cancer cell line
10.25-10.50: Coffee break
11.50-11.20: Johan Swinnen: Lipid metabolism in cancer
11.20-11.35: Emilie Viennois: Androgen and Liver-X-receptors interact in prostate
11.35-11.50: Saara Lehmusvaara: Differences in Gene Expression Induced by Chemical Castration and Anti-Androgens in Prostate Cancer
11.50-12.20: Jocelyn Ceralin: Constitutively active androgen receptor variants : A new field of interest to improve therapeutic strategies for prostate cancer
12.20-13.30: lunch

13.30-14.00: Frederick Wu: The European Male Ageing Study
14.00-14.30: Dirk Vanderschueren: Sex steroids and the musculoskeletal system
14.30-14.45: Hannelore Heemers: Identification of an indirect, SRF-dependent mechanism of androgen action with clinical relevance in prostate cancer
14.45-15.00: Jessica Robinson: Androgen Receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
15.00-15.15: Lee Smith: Androgen Receptor Expression In The Caput Epididymal Epithelium Is Essential For Development Of The Initial Segment And Epididymal Spermatozoa Transit
15.15-15.35 Coffee break
15.35-16.05: Jim Dalton: Recent progress with selective androgen receptor modulators
16.05-16.35: Richard Sharpe: Perinatal androgen action determines male reproductive organ differentiation and function and susceptibility to dysfunction in adulthood
16.35: poster awards and farewell